NZ Algae Firm Developing Omega-3 Production
November 24, 2011
AlgaeIndustryMagazine.com
wen Hembry, in the New Zealand Herald writes that Auckland, New Zealand-based biotechnology company Photonz has made a major step toward commercialization of its marine microalgae-derived omega-3 fatty acid product, or EPA, after transferring its fermentation process to a Canadian facility.
The Canadian facility can operate multi-ton scale fermentations under industrial conditions, with successive harvests. The harvested biomass is then shipped to France for a purification process.
“That is a huge technical step to be able to put the process into other people’s hands and they can make it work,” chief executive Greg Moss-Smith said. “You’re almost in the ball park of normal commercial risk at this point. As a result of the success of this project I have confirmed to our investors that we remain on track to manufacture, in 2012, an industrial scale end-product that addresses a massive opportunity in the US$60 billion cardiovascular disease market [in the US].”
Go to 
Page
Copyright ©2010-2011 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.
Visit the A.I.M. Archives
FREE Algae News & Updates
